,date,symbol,fillingDate,acceptedDate,period,netIncome,depreciationAndAmortization,deferredIncomeTax,stockBasedCompensation,changeInWorkingCapital,accountsReceivables,inventory,accountsPayables,otherWorkingCapital,otherNonCashItems,netCashProvidedByOperatingActivities,investmentsInPropertyPlantAndEquipment,acquisitionsNet,purchasesOfInvestments,salesMaturitiesOfInvestments,otherInvestingActivites,netCashUsedForInvestingActivites,debtRepayment,commonStockIssued,commonStockRepurchased,dividendsPaid,otherFinancingActivites,netCashUsedProvidedByFinancingActivities,effectOfForexChangesOnCash,netChangeInCash,cashAtEndOfPeriod,cashAtBeginningOfPeriod,operatingCashFlow,capitalExpenditure,freeCashFlow,link,finalLink
0,2019-12-31,INMB,2020-03-11 00:00:00,2020-03-10 20:28:23,FY,-7678310.0,0.0,0.0,4096538.0,7038830.0,24076000,0.0,19557.0,7064400.0,2554540.0,-5384660.0,0.0,0.0,0.0,0.0,-15044.0,0.0,0.0,12209021,12209020,0.0,6995525.0,12209020,-15040.0,6809320.0,6995520.0,186200.0,-5384660.0,0.0,-5384660.0,https://www.sec.gov/Archives/edgar/data/1711754/000121390020005916/0001213900-20-005916-index.html,https://www.sec.gov/Archives/edgar/data/1711754/000121390020005916/f10k2019_inmunebioinc.htm
